"More realistic" study of stents shows limited success
This article was originally published in Clinica
Executive Summary
A major international trial has concluded that stents are best for high-risk coronary artery disease patients but show little benefit over angioplasty for patients with stable disease. In addition, stenting is around $1,000 more expensive per patient.